Product
JCXH-105
1 clinical trial
3 indications
Indication
Herpes ZosterIndication
Herpes zosterIndication
Infectious DiseaseClinical trial
A Phase 1 Randomized, Double-Blinded, Active-Controlled, 2-Dose Study to Assess the Safety and Immunogenicity of a Herpes Zoster (HZ) Vaccine, JCXH-105, in Healthy Subjects 50 to 69 Years of Age.Status: Active (not recruiting), Estimated PCD: 2024-02-23